Kura Oncology (NASDAQ:KURA – Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.59) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.56) by ($0.03), Briefing.com reports. During the same period in the prior year, the business earned ($0.50) EPS. The company’s revenue was up .0% on a […]
Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) has received a consensus rating of “Moderate Buy” from the eight brokerages that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1 year price objective among […]
Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the eight ratings firms that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1-year price target among brokers […]
Pale Fire Capital SE bought a new stake in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm bought 10,050 shares of the company’s stock, valued at approximately $92,000. Other hedge funds have also recently added to or reduced […]
Pale Fire Capital SE acquired a new position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 10,050 shares of the company’s stock, valued at approximately $92,000. Other institutional investors and hedge funds have also […]